Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · IEX Real-Time Price · USD
6.63
-0.46 (-6.49%)
At close: Mar 28, 2024, 3:51 PM
6.40
-0.23 (-3.47%)
After-hours: Mar 28, 2024, 6:43 PM EDT

Aileron Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018201720162015
Selling, General & Admin
9.689.69.3312.2913.458.777.895.06
Research & Development
17.9717.0111.1717.6618.4514.2410.287.83
Operating Expenses
27.6526.6120.529.9631.923.0118.1712.89
Operating Income
-27.65-26.61-20.5-29.96-31.9-23.01-18.17-12.89
Other Expense / Income
-0.32-0.440.66-0.59-0.36-0.4-0.05-0.01
Pretax Income
-27.33-26.16-21.16-29.37-31.55-22.6-18.12-12.88
Net Income
-27.33-26.16-21.16-29.37-31.55-22.6-18.12-12.88
Preferred Dividends
000000.040.080.07
Net Income Common
-27.33-26.16-21.16-29.37-31.55-22.65-18.2-12.95
Shares Outstanding (Basic)
54211000
Shares Outstanding (Diluted)
54211000
Shares Change
2.23%154.70%42.11%66.48%98.01%1632.24%7.23%-
EPS (Basic)
-6.02-5.89-12.20-24.00-42.80-60.80-847.00-646.20
EPS (Diluted)
-6.02-5.89-12.20-24.00-42.80-60.80-847.00-646.20
Free Cash Flow
-24.87-23.85-20.27-26.63-32.35-20.67-15.01-11.8
Free Cash Flow Per Share
-5.48-5.37-11.63-21.70-43.90-55.55-698.84-589.15
EBITDA
-27.16-26.04-20.99-29.21-31.33-22.48-17.89-12.55
Depreciation & Amortization
0.170.120.160.160.220.130.230.33
EBIT
-27.33-26.16-21.16-29.37-31.55-22.6-18.12-12.88
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).